A Phase I, Open-Label, Multicenter Study of FT536as Monotherapy and in Combination with MonoclonalAntibodies in Subjects with Advanced Solid Tumors

Project: Research project

Project Details

Description

A Phase I, Open-Label, Multicenter Study of FT536 as Monotherapy and in Combination with Monoclonal Antibodies in Subjects with Advanced Solid Tumors
StatusFinished
Effective start/end date9/22/226/5/23

Funding

  • FATE THERAPEUTICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.